| ABIRISK
|
Pre-FAIRification
assessment |
2021-03-10 |
RDA
indicator v0.05 |
N/A |
34.15% |
45.00% |
23.81% |
|
|
Post-FAIRification
assessment |
2022-04-06 |
RDA
indicator v0.05 |
N/A |
60.98% |
80.00% |
42.86% |
|
| APPROACH
|
Pre-FAIRification
assessment |
2021-03-19 |
RDA
indicator v0.05 |
N/A |
21.95% |
30.00% |
14.29% |
|
|
Post-FAIRification
assessment |
2022-04-06 |
RDA
indicator v0.05 |
N/A |
58.54% |
80.00% |
38.10% |
|
| CARE
|
Pre-FAIRification
assessment |
2021-03-10 |
RDA
indicator v0.05 |
CARE dataset in Zenodo |
37.50% |
55.00% |
20.00% |
Some indicators are not applicable to this dataset |
|
Post-FAIRification
assessment |
2021-10-01 |
RDA
indicator v0.05 |
CARE FAIRified
dataset in ChEMBL |
92.50% |
90.00% |
95.00% |
|
| EBiSC
|
Pre-FAIRification
assessment |
N/A |
RDA
indicator v0.05 |
N/A |
51.22% |
90.00% |
23.81% |
|
|
|
Post-FAIRification
assessment |
N/A |
RDA
indicator v0.05 |
N/A |
80.49% |
90.00% |
71.43% |
|
| eTOX
|
Pre-FAIRification
assessment |
2019-10-17 |
RDA
indicator v0.02 |
eTOX dataset |
10% |
25% |
21.43% |
Some indicators are not applicable to this dataset |
|
Post-FAIRification
assessment |
2019-12-10 |
RDA
indicator v0.02 |
eTOX FAIRified
dataset |
43.10% |
50.00% |
53.57% |
|
| IMIDIA
|
Pre-FAIRification
assessment |
2022-01-26 |
RDA
indicator v0.05 |
N/A |
36.59% |
35.00% |
38.10% |
|
|
|
Post-FAIRification
assessment |
2022-01-26 |
RDA
indicator v0.05 |
N/A |
63.41% |
80.00% |
47.62% |
|
| ND4BB
|
Pre-FAIRification
assessment |
2019-11-23 |
RDA
indicator v0.03 |
ND4BB AMR dataset, raw data |
36.00% |
47.06% |
32.00% |
Some indicators are not applicable to this dataset |
|
Post-FAIRification
assessment |
2019-11-23 |
RDA
indicator v0.03 |
ND4BB AMR dataset, raw data |
36.00% |
47.06% |
32.00% |
the FAIRification pratices were not reflected in the post-FAIRification score |
|
OncoTrack
|
Pre-FAIRification
assessment |
2019-12-09 |
RDA
indicator v0.03 |
OncoTrack
public sample metadata, raw data |
15% |
23% |
6% |
|
|
Post-FAIRification
assessment |
2019-12-10 |
RDA
indicator v0.03 |
OncoTrack
public sample metadata, FAIRifed v1 |
35% |
46% |
13% |
Some indicators are not applicable to this dataset |
| RESOLUTE |
Pre-FAIRification
assessment |
2019-10-14 |
RDA
indicator v0.02 |
RESOLUTE transcriptomics huh-7 cell line
|
58.7% |
63.84% |
66.67% |
Some indicators are not applicable to this dataset |
|
Post-FAIRification
assessment |
2019-12-10 |
RDA
indicator v0.03 |
RESOLUTE
transcriptomics, FAIRified sample metadata |
82% |
82% |
71% |
The indicator version is different with the Pre-assessment |
| RHAPSODY |
Pre-FAIRification
assessment |
2022-01-26 |
RDA
indicator v0.05 |
N/A
|
41.46% |
45.00% |
38.10% |
|
|
Post-FAIRification
assessment |
|
RDA
indicator v0.05 |
N/A |
63.41% |
80.00% |
47.62% |
|
